Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Longeveron (LGVN)
NASDAQ:LGVN
Holding LGVN?
Track your performance easily
LGVN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.77 - $14.80
Previous Close$1.77
Volume214.96K
Average Volume (3M)479.38K
Market Cap
$26.26M
Enterprise Value$5.08M
Total Cash (Recent Filing)$22.78M
Total Debt (Recent Filing)$1.60M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Mar 07, 2025EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.33
Shares Outstanding14,836,775
10 Day Avg. Volume402,048
30 Day Avg. Volume479,379
Standard Deviation1.05
R-Squared0.00018
Alpha0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.02
Price to Sales (P/S)13.23
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.68
Enterprise Value/Gross Profit23.00
Enterprise Value/Ebitda-0.31
Forecast
1Y Price Target
$10.00Price Target Upside468.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Longeveron News
Ownership Overview
14.00% Insiders
0.63% Mutual Funds
0.20% Other Institutional Investors
84.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
LGVN FAQ
What was Longeveron’s price range in the past 12 months?
Longeveron lowest stock price was $0.77 and its highest was $14.80 in the past 12 months.
What is Longeveron’s market cap?
Currently, no data Available
When is Longeveron’s upcoming earnings report date?
Longeveron’s upcoming earnings report date is Mar 07, 2025 which is in 72 days.
How were Longeveron’s earnings last quarter?
Longeveron released its earnings results on Nov 12, 2024. The company reported -$0.34 earnings per share for the quarter, beating the consensus estimate of -$0.39 by $0.05.
Is Longeveron overvalued?
According to Wall Street analysts Longeveron’s price is currently Undervalued.
Does Longeveron pay dividends?
Longeveron does not currently pay dividends.
What is Longeveron’s EPS estimate?
Longeveron’s EPS estimate is -$0.37.
How many shares outstanding does Longeveron have?
Longeveron has 13,352,770 shares outstanding.
What happened to Longeveron’s price movement after its last earnings report?
Longeveron reported an EPS of -$0.34 in its last earnings report, beating expectations of -$0.39. Following the earnings report the stock price went down -7.826%.
Which hedge fund is a major shareholder of Longeveron?
Among the largest hedge funds holding Longeveron’s share is Gamco Investors, Inc. ET AL. It holds Longeveron’s shares valued at N/A.
---
Company Description
Longeveron
Longeveron LLC is a biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS).
---
LGVN Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a largely positive outlook with significant milestones achieved in HLHS and Alzheimer's programs, financial growth, and a strategic focus on advancing stem cell therapies. However, challenges remain in Alzheimer's development and securing additional financing.Read More>---
LGVN Stock 12 Month Forecast
Average Price Target
$10.00
▲(468.18% Upside)
Technical Analysis
Best Analysts Covering LGVN
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-71.81%
reiterated a buy rating 4 months ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -71.81% per trade.
---